Investors bought shares of UnitedHealth Group Incorporated (NYSE:UNH) on weakness during trading hours on Tuesday. $115.67 million flowed into the stock on the tick-up and $90.63 million flowed out of the stock on the tick-down, for a money net flow of $25.04 million into the stock. Of all equities tracked, UnitedHealth Group had the 19th highest net in-flow for the day. UnitedHealth Group traded down ($1.62) for the day and closed at $194.68
Several analysts have recently weighed in on the stock. Barclays PLC increased their price target on shares of UnitedHealth Group from $200.00 to $217.00 and gave the company an “overweight” rating in a research note on Wednesday, July 19th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective for the company in a research report on Thursday, September 21st. Cowen and Company reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Friday, July 14th. Jefferies Group LLC reaffirmed a “buy” rating and set a $215.00 price objective on shares of UnitedHealth Group in a research report on Friday, August 18th. Finally, BidaskClub cut shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. Three research analysts have rated the stock with a hold rating and twenty-three have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $203.59.
The company’s 50-day moving average price is $196.60 and its 200-day moving average price is $184.31. The firm has a market cap of $188.79 billion, a P/E ratio of 23.46 and a beta of 0.63.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. During the same quarter last year, the company earned $1.96 EPS. The company’s revenue for the quarter was up 7.7% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 19th. Investors of record on Friday, September 8th were issued a $0.75 dividend. The ex-dividend date was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.54%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.
In related news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the completion of the transaction, the director now owns 1,818,898 shares in the company, valued at approximately $348,700,935.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Larry C. Renfro sold 50,574 shares of the stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the transaction, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. In the last ninety days, insiders sold 76,174 shares of company stock worth $14,981,909. Corporate insiders own 0.89% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Blue Chip Partners Inc. bought a new position in UnitedHealth Group in the 2nd quarter valued at about $110,000. Bruderman Asset Management LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at about $114,000. Patriot Financial Group Insurance Agency LLC grew its position in UnitedHealth Group by 1,722.9% in the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares in the last quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its position in UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after buying an additional 520 shares in the last quarter. Finally, BDO Wealth Advisors LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at about $121,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.